Information Provided By: 
Fly News Breaks for July 26, 2017
TMO
Jul 26, 2017 | 15:40 EDT
Wells Fargo analyst Tim Evans would use weakness in Thermo Fisher shares as a buying opportunity saying his long-term positive view of the pharma market is unchanged, but investor expectations may be a bit too high. Evans said Thermo has more flexibility on capital deployment than peers, giving it advantages when it comes to acquisitions or share repurchases. Shares are Outperform rated with a $200 price target.
News For TMO From the Last 2 Days
